1. Home
  2. ISTR vs CRVS Comparison

ISTR vs CRVS Comparison

Compare ISTR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISTR
  • CRVS
  • Stock Information
  • Founded
  • ISTR 2006
  • CRVS 2014
  • Country
  • ISTR United States
  • CRVS United States
  • Employees
  • ISTR N/A
  • CRVS N/A
  • Industry
  • ISTR Major Banks
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISTR Finance
  • CRVS Health Care
  • Exchange
  • ISTR Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • ISTR 166.7M
  • CRVS 161.4M
  • IPO Year
  • ISTR 2014
  • CRVS 2016
  • Fundamental
  • Price
  • ISTR $18.03
  • CRVS $5.04
  • Analyst Decision
  • ISTR Buy
  • CRVS Buy
  • Analyst Count
  • ISTR 1
  • CRVS 3
  • Target Price
  • ISTR $13.50
  • CRVS $5.75
  • AVG Volume (30 Days)
  • ISTR 39.6K
  • CRVS 414.7K
  • Earning Date
  • ISTR 10-17-2024
  • CRVS 11-05-2024
  • Dividend Yield
  • ISTR 2.18%
  • CRVS N/A
  • EPS Growth
  • ISTR N/A
  • CRVS N/A
  • EPS
  • ISTR 1.53
  • CRVS N/A
  • Revenue
  • ISTR $80,646,000.00
  • CRVS N/A
  • Revenue This Year
  • ISTR N/A
  • CRVS N/A
  • Revenue Next Year
  • ISTR $13.81
  • CRVS N/A
  • P/E Ratio
  • ISTR $12.00
  • CRVS N/A
  • Revenue Growth
  • ISTR N/A
  • CRVS N/A
  • 52 Week Low
  • ISTR $9.07
  • CRVS $1.05
  • 52 Week High
  • ISTR $18.99
  • CRVS $5.22
  • Technical
  • Relative Strength Index (RSI)
  • ISTR 48.93
  • CRVS 73.92
  • Support Level
  • ISTR $17.39
  • CRVS $3.90
  • Resistance Level
  • ISTR $18.09
  • CRVS $4.75
  • Average True Range (ATR)
  • ISTR 0.42
  • CRVS 0.36
  • MACD
  • ISTR -0.11
  • CRVS 0.04
  • Stochastic Oscillator
  • ISTR 17.22
  • CRVS 93.44

About ISTR Investar Holding Corporation

Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: